
ÜTS Tracking and Monitoring: The Traceability Obligation
The traceability obligation in ÜTS: the components of the UDI system, registration by class and the device identifier schedule, the template file for bulk data transfer and registration consistency.
In your own stock software a product shows 4,200 units, the ÜTS table gives another number, you cannot find where the difference comes from, and at the same time you are wondering how this difference will be explained in an inspection. The second problem is this: instead of entering data into the system one by one, you want to transfer it from your own software, but you cannot find a written provision on what the way to do that is.
This page deals with the fact that traceability is a record-keeping obligation and not a software feature, with the articles this obligation comes from, with the only method of bulk data transfer to ÜTS that is written in the Manual, with how the difference between the firm's own record and the ÜTS record is closed, and with what you should be able to present in an inspection. The definition of a unique device and the types of movement are the subject of separate pages; here the system side and the proof side are covered.
The sources are the Medical Device Regulation (Tıbbi Cihaz Yönetmeliği) published in the Official Gazette No. 31499 (bis) of 2/6/2021, the Manual on Registration Procedures of Medical Devices in the Product Tracking System (Tıbbi Cihazların Ürün Takip Sistemine Kayıt Süreçlerine İlişkin Kılavuz), and the Medical Device Sales, Advertising and Promotion Regulation (Tıbbi Cihaz Satış, Reklam ve Tanıtım Yönetmeliği) published in the Official Gazette No. 29001 of 15/5/2014.
Traceability is not a software job, it is an obligation to be able to present
When traceability is mentioned, the first thing that comes to mind is scanning barcodes; its counterpart in the legislation is being able to answer when a question is asked. Article 25(1) of the Medical Device Regulation says that distributors and importers will cooperate with manufacturers or authorised representatives to achieve an appropriate level of traceability of devices.
The real obligation is in the second paragraph. Article 25(2) of the same Regulation provides that economic operators must be able to identify to the Agency and, where the device is made available on the EU market, to the competent authorities of the relevant EU member states, for the period referred to in Article 10(8), every economic operator to whom they have directly supplied a device, every economic operator who has directly supplied them with a device, and every health institution or health professional to whom they have directly supplied a device.
The verb of the paragraph is "must be able to identify". That is, the criterion is not that you have kept a record, but that you can put that record forward when a request arrives. If the data you hold cannot be queried, the obligation has not been fulfilled.
The basis of the ÜTS obligation is in the Regulation, its content is in the manuals
Going straight to the Manual to look for the source of ÜTS would be an incomplete reading. Article 34(1) of the Medical Device Regulation says that, without prejudice to the EUDAMED-related obligations set out in this Regulation, economic operators established in the country, notified bodies, health institutions, health professionals and other relevant persons will fulfil their obligations relating to the national product tracking system. Paragraph 2 of the same article adds that the said obligations relating to ÜTS will be determined by the regulations published by the Agency.
Article 3(1)(b) of the Manual builds the same link from the other direction: the Manual was prepared on the basis of Article 34 of the Medical Device Regulation. Point (c) of the same paragraph also shows Article 32 of the In Vitro Diagnostic Medical Device Regulation as a basis.
The result is this: you look for the existence of an obligation relating to ÜTS in the Regulation, and for its scope and its screen counterpart in the Agency's regulations. Mixing the two leads either to inventing an obligation that has no basis or, conversely, to ignoring an obligation that does.
The UDI system has four parts, and the third one concerns you
Article 27(1) of the Medical Device Regulation says that the Unique Device Identification System allows the identification of devices and facilitates their traceability, and then lists what the system consists of: point (a) covers the production of a UDI, point (b) the placing of the UDI on the label or packaging of the device, point (c) the keeping of a record of the UDI by economic operators, health institutions and health professionals under the conditions in paragraphs 8 and 9, and point (ç) the establishment of the UDI database referred to in Article 28.
The first two parts are the manufacturer's job. The third part, that is, keeping the record, is the job of everyone in the supply chain, and all the discussions on the ÜTS side are really the application of this point (c).
One obligation on the manufacturer's side should also be noted, because the lists requested from you originate there: paragraph 7 of the same article says that the manufacturer will keep up to date the list of all UDIs it has assigned, as part of the technical documentation referred to in Annex II. You need to be able to compare your own record with this list of the manufacturer.
Who records what changes with the class
This is one of the most clearly drawn distinctions in the source, and firms often take on either more or less of a burden than applies to them.
Article 27(8) of the Medical Device Regulation says that economic operators will record and keep, preferably by electronic means, the UDIs of the devices they supply or that have been supplied to them, if these devices are class III implantable devices or belong to the devices, device categories or groups determined by the Commission.
Point (a) of paragraph 9 of the same article limits the same obligation to class III implantable devices for health institutions. Point (b) of the same paragraph says that, for devices other than class III implantable devices, record-keeping of UDIs by health institutions is encouraged and may be requested where necessary; point (c) repeats the same wording for health professionals.
The source here sets up two different legal regimes: on one side an obligation to record and keep, on the other encouragement and the possibility of being requested. Wiping out the difference and presenting everything as mandatory, or acting as if the encouragement did not exist at all, is contrary to the text.
The schedule for the UDI carrier obligation differs class by class
Whether not seeing a UDI carrier on a label is a non-conformity depends on the class of the device and on the date. Article 111(1)(c) of the Medical Device Regulation phases in the entry into force of Article 27(4): for implantable devices and class III devices, on its date of publication, effective from 26/5/2021; for class IIa and class IIb devices, on 26/5/2023; for class I devices, on 26/5/2025.
Sub-point 4 of the same point gives a separate schedule for reusable devices: for reusable devices that carry the UDI carrier on the device itself, 26/5/2023 for implantable devices and class III devices, 26/5/2025 for class IIa and class IIb devices, and 26/5/2027 for class I devices.
Use this schedule when you go through your inventory. Two devices sitting in the same warehouse may not have the same carrier obligation.
The only method for bulk data transfer to ÜTS written in the Manual is the template file
An expectation needs to be corrected here at the outset: none of these three sources regulates a web service, an application programming interface or a similar technical integration method. The bulk notification method in the Manual is the filling in and uploading of a template file that is downloaded. A plan that assumes you will connect directly from your own software to ÜTS cannot be built on these sources.
The Manual sets aside eight separate articles for bulk notification, and each corresponds to a different operation. Article 31(1) of the Manual regulates the "Bulk MDD/AIMDD/IVDD Add/Update Medical Device" ("Toplu MDD/AIMDD/IVDD Tıbbi Cihaz Ekle/Güncelle") screen for devices under the Old Medical Device Regulations; Article 32(1) regulates the bulk add and update operation for devices under the MDR; Article 33 regulates the same operation under the IVDR. Article 34(2) of the Manual shows the bulk device deletion screen, Article 35(1) the update without application, Article 36(2) the bulk addition of placing-on-the-market information, Article 37(2) the addition of storage and use conditions, and Article 38(2) the addition of measurement information.
The file rules are also written down, and most errors come from these rules. Article 31(4) of the Manual says that in the template Excel file the red columns indicate mandatory fields and the yellow columns indicate fields that are mandatory depending on another field being filled in. Paragraph 5 of the same article says that the template file is uploaded compressed in zip format together with the label information files of the relevant devices and the different packaging image files; paragraph 6 says that these files must be directly inside the zip file and not in separate folders; paragraph 7 says that the size of the zip file can be at most 200 MB; and paragraph 8 says that Turkish characters cannot be used in file names.
Article 35(4) of the Manual points to a trap: if the "Product Catalogue List" ("Ürün Katalog Listesi") field in the template is left empty and a product catalogue linked to the device exists before the operation, the relationship between the device and the catalogue is cut. A bulk update does not only add; through a field you leave empty, it also deletes.
It should also be added that bulk entry does not remove the application obligation. Article 31(10) of the Manual says that, for the conformity of a device registration or update notification made under this article to be assessed, a device application must be made to the Agency as mentioned in Article 40; the same provision is repeated in Article 37(5) and Article 38(5).
How to close the difference between your own record and the ÜTS record
The same product standing in ÜTS with different data under more than one firm is a common situation with imported products, and it is not resolved by chance. Article 43(1) of the Manual says that, if a device registered in ÜTS under the same barcode has records belonging to different firms and there are data differences between these records, the relevant product parameters must be made identical and consistent in ÜTS before the first device application to be made under Article 40.
The process is a reconciliation mechanism. Paragraph 2 of the same article says that, in case of inconsistency, the firm will create a request application according to the work steps in Article 44. Paragraph 3 of the same article says that the request is submitted for the opinion of the other firms with a record under the same barcode, when it is in "Registered" ("Kayıtlı") or "Unique Product Exists in the System" ("Sistemde Tekil Ürün Var") status; that at this stage the request is in "Other Firms' Opinions Awaited" ("Diğer Firmaların Görüşleri Bekleniyor") status; that the period for giving an opinion is 5 days; and that firms that do not give an opinion within this period are deemed to have accepted the request.
The result splits into two paths. Paragraph 4 of the same article says that, if all firms approve, the request is deemed unanimously accepted for fields that do not require Agency assessment, and ÜTS automatically corrects the relevant fields in the device records of all firms. Paragraph 7 of the same article says that requests relating to fields requiring Agency assessment, such as "Class", "GMDN" and "EMDN", are in every case submitted to the Agency's assessment and approval.
Take one side effect into account as well. Paragraph 11 of the same article says that, if as a result of updating the "Class" data field the documents linked to the relevant device records become inconsistent with the device class, revision data will be given to the devices with the relevant barcode. Correcting one field may create a non-conformity somewhere else.
Record retention periods are not a single number
The question "how many years will we keep the records" has no single answer, and the sources give different periods. It is necessary to know this difference as it is, rather than hide it.
Article 10(8)(a) of the Medical Device Regulation says that manufacturers will keep the technical documentation, the EU declaration of conformity and, where applicable, copies of the relevant certificates for at least 10 years after the last device covered by the declaration has been placed on the market, and for implantable devices this period is at least 15 years. Article 25(2) of the same Regulation ties the obligation to be able to present supply chain records directly to this period.
On the sales side there are two separate periods. Article 8(6) of the Sales, Advertising and Promotion Regulation says that the sales centre will keep for five years the documents relating to the activities it carries out under this Regulation and will present them at the request of the Agency or the directorate. Article 31(3) of the same Regulation sets a separate and longer period for traceability records: sales centres keep, in an orderly manner and on the basis of parameters such as batch, serial, lot, brand and model, the record of the name, trade name or brand and contact details of the previous and, if any, the next economic operator in the supply chain and of other information that will facilitate the tracking of devices, keep these records for at least ten years from the date they start to make the device available on the market, and submit them to the Agency on request.
The source does not reconcile these two periods with each other. The five-year period relates to general activity documents, the ten-year period to traceability records, and the 10 and 15-year periods on the manufacturer's side stand apart from both. Setting up your archive policy according to the longest period is the sensible way to manage this uncertainty.
Paragraph 3 of Article 31 also says on what parameters the record will be kept: batch, serial, lot, brand and model. A record kept only by product name and quantity does not meet this paragraph.
What you should be able to present in an inspection
An inspection is the real test of your record system, and what will be requested is written down.
Article 27(1) of the Sales, Advertising and Promotion Regulation says that sales centres will be inspected by the directorate at least once every two years, and by the Agency as well where deemed necessary. Paragraph 4 of the same article says that the responsible manager of the sales centre is obliged to provide every facility during these inspections and to give every piece of information, document and book requested. Article 29(1)(c) of the same Regulation says that, if the information and documents requested by the inspection team are not given or the inspection is obstructed, the activity of the sales centre will be temporarily suspended for fifteen days.
The Agency's authority is also broad. Article 90(3)(a) of the Medical Device Regulation says that the Agency may request economic operators to have the necessary documentation and information available and, where justified, to provide the necessary device samples free of charge or to give access to the devices; point (b) says that the Agency will carry out announced and, where necessary, unannounced inspections at the premises of economic operators, together with suppliers and contractors and, where necessary, at the premises of professional users.
Paragraphs 6 and 7 of the same article regulate the written result of the inspection: following each inspection, the Agency prepares a report on the findings relating to conformity; this report states the necessary corrective actions; the content of the report is communicated to the economic operator subject to the inspection; and the operator is given the opportunity to submit comments before the final report is adopted.
The consequence of failing to provide information and documentation is also written down. Article 10(14)(b) of the same Regulation says that, if the manufacturer does not cooperate or the information and documentation provided are incomplete or wrong, the Agency may take all appropriate measures to prohibit or restrict the making available of the device on the market, or to withdraw or recall the device.
Traceability data is used in vigilance
The quality of your record system is measured when a serious incident occurs. Article 27(5) of the Medical Device Regulation says that the UDI will be used for reporting serious adverse events and field safety corrective actions under Article 85.
The reporting periods are written in Article 85 of the same Regulation, and they are tight. Paragraph 3 of the same article says that the manufacturer will report any serious adverse event immediately after establishing a causal relationship between the event and its devices or after such a causal relationship is reasonably likely, and that this period will not exceed 15 days from the date the manufacturer becomes aware of the event. Paragraph 4 of the same article says that the period will not exceed 2 days where a serious public health threat is involved, and paragraph 5 says that it will not exceed 10 days where there is death or an unexpected serious deterioration in a person's state of health.
If you cannot work out within these periods which lot went where, the problem is not in the reporting period, it is in your traceability record.
Wrong data affects your access to the system
The sanction for data quality is not only the rejection of an application. Article 31(4) of the Sales, Advertising and Promotion Regulation says that the Agency will issue manuals on the registration of devices into the registration and information management system, that sales centres will set up an infrastructure in line with these manuals within the stated periods and will register the devices in the system, and that the accuracy of the information on the devices registered in the system is the responsibility of the sales centre that makes the product registration.
Article 28/A(1) of the same Regulation says that, if the Agency finds that applications have been made to its registration and information management systems with false information and documents, it may restrict the access of the persons or institutions who carry out these operations to the relevant systems; paragraph 2 says that, if it is established that operations were repeatedly carried out contrary to the determined procedures and principles, the trainings these persons received under Article 26(10) will be cancelled.
Article 26(10) of the same Regulation already requires persons who carry out registration operations to successfully complete the trainings determined by the Agency. Cancellation of the training means that the person can no longer carry out operations in the system; this ties data quality to a matter of individual authorisation.
Matters the sources do not regulate
To be honest, these three texts do not regulate what many firms expect under the heading of "ÜTS integration".
Web service and interface: There is no provision in the Manual regulating a web service, an application programming interface or a direct system connection. The method that is regulated is the template file upload described in Articles 31 to 38 of the Manual.
Stock reconciliation procedure: There is no provision in these sources on how often a firm will compare its own stock record with the ÜTS record. What exists is the obligation to be able to present under Article 25(2) of the Medical Device Regulation and the obligation to keep records in an orderly manner under Article 31(3) of the Sales, Advertising and Promotion Regulation. The frequency of reconciliation is determined by the firm itself in a way that will meet these two obligations.
Field list of the unique device movement screens: The Manual regulates the device and document registration processes; it does not regulate, field by field, the content of the unique device movement notification screens.
Rather than filling these gaps with an invented procedure, the right approach is to work backwards from the obligation that has a basis.
What we do on traceability, and whose responsibility the record is
Within medical device ÜTS registration consultancy, the outputs we produce on the tracking and monitoring side are these:
Reconciliation table: We compare the firm's own stock record with the device records in ÜTS on a barcode basis and work out, line by line, which operation each difference comes from.
Bulk notification file: We determine which screen among Articles 31 to 38 of the Manual is to be used, fill in the template file in line with the distinction between mandatory and conditionally mandatory columns, and adapt the zip structure and file naming of the attachments to Article 31(5) to (8) of the Manual.
Same-barcode mismatch file: Under Articles 43 and 44 of the Manual, we prepare the imported product data change request with its reasons and evidence; we also mark separately the fields that require Agency assessment.
Retention period map: We write down which record will be kept for how many years under which provision, without hiding the differences between the periods.
Inspection rehearsal: We list the information and documents that may be requested under Article 27(4) of the Sales, Advertising and Promotion Regulation and Article 90(3) of the Medical Device Regulation, and report which of them cannot be presented today.
UDI carrier schedule check: We read your portfolio against the dates in Article 111(1)(c) of the Medical Device Regulation.
What we cannot do is just as clear. We cannot make the record itself true to fact on your behalf; Article 31(4) of the Sales, Advertising and Promotion Regulation leaves the accuracy of the data to the firm that makes the record. The obligation to present to the Agency the previous and next links of the supply chain lies with the economic operator itself under Article 25(2) of the Medical Device Regulation. Serious adverse event reporting belongs to the manufacturer under Article 85 of the same Regulation, and keeping the technical documentation belongs, again, to the manufacturer under Article 10(8)(a); a consultant cannot produce this documentation or keep it in the manufacturer's place. Nor can we promise an integration method that is not regulated in the Manual.
The way of working is as follows: the firm opens a user authorisation for the consultant from its own ÜTS firm page, bulk notification files and records are entered into the system with the "Medical Device Registration Operator" ("Tıbbi Cihaz Kayıt Elemanı") authorisation, and the person who electronically signs the application remains the firm's signatory.
